Local and systemic isotype-specific antibody responses to equine influenza virus infection versus conventional vaccination

Vaccine ◽  
1998 ◽  
Vol 16 (13) ◽  
pp. 1306-1313 ◽  
Author(s):  
K Nelson
2013 ◽  
Vol 159 (5) ◽  
pp. 1159-1162 ◽  
Author(s):  
Xin Yin ◽  
Gang Lu ◽  
Wei Guo ◽  
Ting Qi ◽  
Jian Ma ◽  
...  

2017 ◽  
Vol 36 (3) ◽  
pp. 789-798
Author(s):  
P.F. FAVARO ◽  
D. REISCHAK ◽  
P.E. BRANDAO ◽  
E.M.C. VILLALOBOS ◽  
E.M.S. CUNHA ◽  
...  

2010 ◽  
Vol 84 (8) ◽  
pp. 3974-3983 ◽  
Author(s):  
Roberto A. Saenz ◽  
Michelle Quinlivan ◽  
Debra Elton ◽  
Shona MacRae ◽  
Anthony S. Blunden ◽  
...  

ABSTRACT A key question in pandemic influenza is the relative roles of innate immunity and target cell depletion in limiting primary infection and modulating pathology. Here, we model these interactions using detailed data from equine influenza virus infection, combining viral and immune (type I interferon) kinetics with estimates of cell depletion. The resulting dynamics indicate a powerful role for innate immunity in controlling the rapid peak in virus shedding. As a corollary, cells are much less depleted than suggested by a model of human influenza based only on virus-shedding data. We then explore how differences in the influence of viral proteins on interferon kinetics can account for the observed spectrum of virus shedding, immune response, and influenza pathology. In particular, induction of high levels of interferon (“cytokine storms”), coupled with evasion of its effects, could lead to severe pathology, as hypothesized for some fatal cases of influenza.


PLoS ONE ◽  
2014 ◽  
Vol 9 (1) ◽  
pp. e85616 ◽  
Author(s):  
Nyamdavaa Khurelbaatar ◽  
Whitney S. Krueger ◽  
Gary L. Heil ◽  
Badarchiin Darmaa ◽  
Daramragchaa Ulziimaa ◽  
...  

2000 ◽  
Vol 13 (2) ◽  
pp. 237-247 ◽  
Author(s):  
P.P. HEINEN ◽  
A.P. van NIEUWSTADT ◽  
J.M.A. POL ◽  
E.A. de BOER-LUIJTZE ◽  
J.T. van OIRSCHOT ◽  
...  

2020 ◽  
Author(s):  
Minami Nagai ◽  
Miyu Moriyama ◽  
Takeshi Ichinohe

Abstract Background: Gut microbiota and these microbial-derived products play a critical role in the induction of adaptive immune responses to influenza virus infection. However, the role of nasal bacteria in the induction of the virus-specific adaptive immunity is less clear. Here, we examine whether nasal bacteria critically regulates the generation of influenza virus specific adaptive immune response after infection or intranasal vaccination. Results: We demonstrated that disruption of nasal bacteria by topical mucosal application of antibiotic enhances the virus-specific antibody responses to influenza virus infection. Although intranasal administration of hemagglutinin (HA) vaccine alone was insufficient to induce the HA-specific antibody responses, disruption of nasal bacteria by lysozyme or addition of culturable oral bacteria from a healthy human volunteer rescued inability of the nasal bacteria to generate antibody responses to intranasally administered split-virus vaccines. Myd88-depdnent signaling in the hematopoietic compartment was required for adjuvant activity of intranasally administered oral bacteria. In addition, we found that the oral bacteria-combined intranasal vaccine induced protective antibody response to influenza virus and SARS-CoV-2 infection.Conclusion: We show for the first time that disruption of nasal bacteria enhances protective immune responses to influenza virus and SARS-CoV-2 infection. Our findings here have identified a previously unappreciated role for nasal bacteria in the induction of the virus-specific adaptive immune responses.


Sign in / Sign up

Export Citation Format

Share Document